+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell and Gene Therapy Tools and Reagents Market

  • PDF Icon

    Report

  • 136 Pages
  • November 2024
  • Region: Global
  • BCC Research
  • ID: 6025093
Description Jump to:
The Cell and Gene Therapy Tools and Reagents Market was valued at USD 10 billion in 2024, and is projected to reach USD 16.7 billion by 2029, rising at a CAGR of 10.80%.

Cell and gene therapy (CGT) is emerging as an essential tool for safeguarding human health. Techniques such as chimeric antigen receptor T-cell (CAR-T) therapy have emerged as ways to treat many cancers. The promise of gene therapy using technologies such as clustered regularly interspaced short palindromic repeats (CRISPR) is being realized in clinical trials. Therapies are being scaled up to treat lifethreatening diseases such as cancer and rare gene-based diseases. As these therapies come to the fore, a new market for tools to develop these therapies using standard methodologies is emerging. CGT uses cells and genetic material to fight diseases. Cell therapy involves the transplantation of healthy human cells into a patient’s body to replace or repair diseased or damaged tissue or cells. Gene therapy modifies a patient's genetic material. These are overlapping fields. Some products are developed using both cell and gene therapies. Tools and reagents are required to develop cell and gene therapies.

Report Scope

This report analyzes the global market for cell and gene therapy tools and reagents. The market is segmented by product type, disease or application, end user and region. Product types include gene vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome monitoring, cryopreservation reagents, and solutions and media. Diseases or applications include cancer and rare diseases. End users include pharmaceutical and biotech companies, academic research institutes, and clinical laboratories. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

This report also examines strategies and collaborations, discusses the regulatory landscape, and analyzes macroeconomic factors when considering new technologies, the industry's increasing competitiveness, and emerging customer needs. This report also examines analytical frameworks, such as ESG analysis, patent analysis, competitive analysis, and strategic recommendations, which will aid companies in devising their strategic plans.

The report includes:

  • 44 data tables and 57 additional tables
  • An update on the global market for cell and gene therapy tools and reagents
  • Analyses of the global market trends, with historic market revenue for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • A look at the market potential for the cell and gene therapy tools and reagents in the life sciences industry, market drivers, and forecasts for the market segments of product, application, end user and region
  • Facts and figures pertaining to major market dynamics, product innovations, clinical trials, and government regulations
  • Review of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
  • Coverage of the technological, economic and business considerations of the market, and the vendor landscape
  • Analysis of the industry's regulatory framework and policies, and product pipeline
  • Discussion of ESG challenges and ESG practices in the industry
  • Market share analysis of the key companies in the industry and coverage of their proprietary technologies and strategies
  • Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Sartorius CellGenix GmbH, and Miltenyi Biotec

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
Chapter 2 Market Overview
  • Overview
  • Technology Background: Cell Therapy
  • Types of Cell Therapy
  • Technology Background: Gene Therapy
  • Types of Gene Therapy
  • Approved CGT Products
Chapter 3 Market Dynamics
  • Market Dynamics
  • Market Drivers
  • Investments in CGT Research
  • Capacity Expansions for Clinical and Commercial Manufacturing
  • Increasing Incidence of Chronic Diseases
  • Collaborations and Acquisitions
  • Market Restraints
  • Complexity in Manufacturing and Supply Chain
  • Lack of Skilled Force
  • Market Opportunities
  • Harnessing the Advances in CGT Technologies
  • Regulatory Landscape
  • Gene Therapy Regulations
  • Cell Therapy Regulations
  • Viral and Non-Viral Vectors
  • Media
  • GMP Proteins and Antibodies
  • Leukapheresis
  • CGT Regulations in Europe
Chapter 4 Emerging Technologies and Developments
  • Closed and Automated Systems
  • Single-Use Technologies
Chapter 5 Market Segmentation Analysis
  • Market Trends
  • Segmentation Breakdown
  • Global Market for CGT Tools and Reagents, by Product
  • Immunoassays
  • Bioreactors
  • Leukapheresis
  • GMP Antibodies
  • Multiplex Immunoassays
  • Vectors
  • Cell Separation
  • Cryopreservation
  • Cell Expansion
  • Media
  • GMP Proteins
  • GMP Small Molecules
  • CRS Monitoring
  • Global Market for CGT Tools and Reagents, by Application
  • Cancer
  • Rare Diseases
  • Other Diseases
  • Global Market for CGT Tools and Reagents, by End User
  • Pharmaceutical and Biotech Companies
  • Academic and Research Institutes
  • Clinical Laboratories
  • Geographic Breakdown
  • Global Market for CGT Tools and Reagents, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 6 Competitive Intelligence
  • Ranking of Leading Players
  • Strategies of Leading Companies
  • Product Launches
  • Collaborations and Partnerships
  • Expansions
  • Agreements
  • Acquisitions
  • Others
Chapter 7 Sustainability in the CGT Tool and Reagent Market: ESG Perspective
  • Introduction to ESG
  • ESG Performance in the Industry
  • ESG Practices in the CGT Tool and Reagent Industry
  • Environmental Performance
  • Concluding Remarks
Chapter 8 Appendix
  • Methodology
  • Abbreviations
  • References
  • Company Profiles
  • ABCAM LTD.
  • ADVERUM BIOTECHNOLOGIES INC.
  • AKRON BIOTECH
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE
  • CYTIVA
  • FUJIFILM IRVINE SCIENTIFIC
  • MILTENYI BIOTEC
  • PROTEINTECH GROUP INC.
  • QIAGEN
  • REVVITY
  • SARTORIUS CELLGENIX GMBH
  • STEMCELL TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table A: Global Market for CGT Tools and Reagents, by Application, Through 2029
Summary Table B: Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 1: Approved CGT Products, as of 2024
Table 2: Global Cancer Statistics, 2022
Table 3: Global Market for CGT Tools and Reagents, by Product, Through 2029
Table 4: Global Market for CGT Tools and Reagents for Immunoassays, by Region, Through 2029
Table 5: Global Market for CGT Tools and Reagents for Bioreactors, by Region, Through 2029
Table 6: Global Market for CGT Tools and Reagents for Leukapheresis, by Region, Through 2029
Table 7: Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, Through 2029
Table 8: Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, Through 2029
Table 9: Global Market for CGT Tools and Reagents for Vectors, by Region, Through 2029
Table 10: Global Market for CGT Tools and Reagents for Cell Separation, by Region, Through 2029
Table 11: Global Market for CGT Tools and Reagents for Cryopreservation, by Region, Through 2029
Table 12: Global Market for CGT Tools and Reagents for Cell Expansion, by Region, Through 2029
Table 13: Global Market for CGT Tools and Reagents for Media, by Region, Through 2029
Table 14: Global Market for CGT Tools and Reagents for GMP Proteins, by Region, Through 2029
Table 15: Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, Through 2029
Table 16: Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, Through 2029
Table 17: Global Market for CGT Tools and Reagents, by Application, Through 2029
Table 18: Global Market for CGT Tools and Reagents for Cancer, by Region, Through 2029
Table 19: Global Market for CGT Tools and Reagents for Rare Diseases, by Region, Through 2029
Table 20: Global Market for CGT Tools and Reagents for Other Diseases, by Region, Through 2029
Table 21: Global Market for CGT Tools and Reagents, by End User, Through 2029
Table 22: Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, Through 2029
Table 23: Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, Through 2029
Table 24: Global Market for CGT Tools and Reagents for Clinical Labs, by Region, Through 2029
Table 25: Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 26: North American Market for CGT Tools and Reagents, by Product, Through 2029
Table 27: North American Market for CGT Tools and Reagents, by Application, Through 2029
Table 28: North American Market for CGT Tools and Reagents, by End User, Through 2029
Table 29: European Research Initiatives Focused on Personalized Medicine
Table 30: European Market for CGT Tools and Reagents, by Product, Through 2029
Table 31: European Market for CGT Tools and Reagents, by Application, Through 2029
Table 32: European Market for CGT Tools and Reagents, by End User, Through 2029
Table 33: Asia-Pacific Market for CGT Tools and Reagents, by Product, Through 2029
Table 34: Asia-Pacific Market for CGT Tools and Reagents, by Application, Through 2029
Table 35: Asia-Pacific Market for CGT Tools and Reagents, by End User, Through 2029
Table 36: RoW Market for CGT Tools and Reagents, by Product, Through 2029
Table 37: RoW Market for CGT Tools and Reagents, by Application, Through 2029
Table 38: RoW Market for CGT Tools and Reagents, by End User, Through 2029
Table 39: Leading Companies in the CGT Tool and Reagent Market, 2023
Table 40: Product Launches in the Market for CGT Tools and Reagents, 2021-2024
Table 41: Collaborations and Partnerships in the CGT Tool and Reagent Market, 2022-2024
Table 42: Expansions in the Market for CGT Tools and Reagents, 2022-2024
Table 43: Agreements in the Market for CGT Tools and Reagents, 2022-2024
Table 44: Acquisitions in the CGT Market for Tools and Reagents, 2022-2024
Table 45: Other Developments in the Market for CGT Tools and Reagents, 2023 and 2024
Table 46: Focus Areas in ESG Metrics
Table 47: Environmental Performance Initiatives in the CGT Tool and Reagent Market
Table 48: Social Performance Initiatives in the CGT Tool and Reagent Market
Table 49: Governance Performance Initiatives in the CGT Tool and Reagent Market
Table 50: ESG Rankings for Leaders in the Market for CGT Tools and Reagents, 2024*
Table 51: Abbreviations Used in this Report
Table 52: Abcam Ltd.: Company Snapshot
Table 53: Abcam Ltd.: Financial Performance, FY 2022 and 2023
Table 54: Abcam Ltd.: Product Portfolio
Table 55: Abcam Ltd.: News/Key Developments, 2022 and 2023
Table 56: Adverum Biotechnologies Inc.: Company Snapshot
Table 57: Adverum Biotechnologies Inc.: Financial Performance, FY 2022 and 2023
Table 58: Adverum Biotechnologies Inc.: Product Portfolio
Table 59: Adverum Biotechnologies Inc.: News/Key Developments, 2022-2024
Table 60: Akron Biotech: Company Snapshot
Table 61: Akron Biotech: Product Portfolio
Table 62: Akron Biotech: News/Key Developments, 2022-2024
Table 63: Bio-Rad Laboratories Inc.: Company Snapshot
Table 64: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 65: Bio-Rad Laboratories Inc.: Product Portfolio
Table 66: Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 67: Bio-Techne: Company Snapshot
Table 68: Bio-Techne: Financial Performance, FY 2022 and 2023
Table 69: Bio-Techne: Product Portfolio
Table 70: Bio-Techne: News/Key Developments, 2023 and 2024
Table 71: Cytiva: Company Snapshot
Table 72: Cytiva: Product Portfolio
Table 73: Cytiva: News/Key Developments, 2023 and 2024
Table 74: FUJIFILM Irvine Scientific: Company Snapshot
Table 75: FUJIFILM Irvine Scientific: Product Portfolio
Table 76: FUJIFILM Irvine Scientific: News/Key Developments, 2022 and 2023
Table 77: Miltenyi Biotec: Company Snapshot
Table 78: Miltenyi Biotec: Product Portfolio
Table 79: Miltenyi Biotec: News/Key Developments, 2023 and 2024
Table 80: Proteintech Group Inc.: Company Snapshot
Table 81: Proteintech Group Inc.: Product Portfolio
Table 82: QIAGEN: Company Snapshot
Table 83: QIAGEN: Financial Performance, FY 2022 and 2023
Table 84: QIAGEN: Product Portfolio
Table 85: QIAGEN: News/Key Developments, 2022-2024
Table 86: Revvity: Company Snapshot
Table 87: Revvity: Financial Performance, FY 2022 and 2023
Table 88: Revvity: Product/Solutions Portfolio
Table 89: Revvity: News/Key Developments, 2023 and 2024
Table 90: Sartorius CellGenix GmbH: Company Snapshot
Table 91: Sartorius CellGenix GmbH: Product Portfolio
Table 92: Sartorius CellGenix GmbH: News/Key Developments, 2023 and 2024
Table 93: STEMCELL Technologies: Company Snapshot
Table 94: STEMCELL Technologies: Product Portfolio
Table 95: STEMCELL Technologies: News/Key Developments, 2022-2024
Table 96: Thermo Fisher Scientific Inc.: Company Snapshot
Table 97: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 98: Thermo Fisher Scientific Inc.: Product Portfolio
Table 99: Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023
List of Figures
Summary Figure A: Global Market for CGT Tools and Reagents, by Application, 2021-2029
Summary Figure B: Global Market for CGT Tools and Reagents, by Region, 2021-2029
Figure 1: Market Dynamics of CGT Tools and Reagents
Figure 2: CGT Sector Investments, 2018-2023
Figure 3: CGT Sector Investments, by Deal Type, Q1 2024
Figure 4: Global Market Shares of CGT Tools and Reagents, by Product, 2024
Figure 5: Global Market for CGT Tools and Reagents for Immunoassays, by Region, 2021-2029
Figure 6: Global Market for CGT Tools and Reagents for Bioreactors, by Region, 2021-2029
Figure 7: Global Market for CGT Tools and Reagents for Leukapheresis, by Region, 2021-2029
Figure 8: Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, 2021-2029
Figure 9: Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, 2021-2029
Figure 10: Global Market Shares of Gene Therapy Clinical Trials, by Vector Type, 2022
Figure 11: Global Market for CGT Tools and Reagents for Vectors, by Region, 2021-2029
Figure 12: Global Market for CGT Tools and Reagents for Cell Separation, by Region, 2021-2029
Figure 13: Global Market for CGT Tools and Reagents for Cryopreservation, by Region, 2021-2029
Figure 14: Global Market for CGT Tools and Reagents for Cell Expansion, by Region, 2021-2029
Figure 15: Global Market for CGT Tools and Reagents for Media, by Region, 2021-2029
Figure 16: Global Market for CGT Tools and Reagents for GMP Proteins, by Region, 2021-2029
Figure 17: Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, 2021-2029
Figure 18: Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, 2021-2029
Figure 19: Global Market Shares of CGT Tools and Reagents, by Application, 2024
Figure 20: Global Market for CGT Tools and Reagents for Cancer, by Region, 2021-2029
Figure 21: Global Market for CGT Tools and Reagents for Rare Diseases, by Region, 2021-2029
Figure 22: Global Market for CGT Tools and Reagents for Other Diseases, by Region, 2021-2029
Figure 23: Global Market Shares of CGT Tools and Reagents, by End User, 2024
Figure 24: Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, 2021-2029
Figure 25: Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, 2021-2029
Figure 26: Global Market for CGT Tools and Reagents for Clinical Labs, by Region, 2021-2029
Figure 27: Global Market Shares of CGT Tools and Reagents, by Region, 2024
Figure 28: North American Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 29: North American Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 30: North American Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 31: European Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 32: European Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 33: European Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 34: Asia-Pacific Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 35: Asia-Pacific Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 36: Asia-Pacific Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 37: RoW Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 38: RoW Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 39: RoW Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 40: How a Strong ESG Proposition Benefits Businesses
Figure 41: Abcam Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42: Abcam Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 44: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45: Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 46: Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 47: QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 48: QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 49: Revvity: Revenue Share, by Business Unit, FY 2023
Figure 50: Revvity: Revenue Share, by Country/Region, FY 2023
Figure 51: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 52: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

Companies Mentioned

  • Abcam Ltd.
  • Adverum Biotechnologies Inc.
  • Akron Biotech
  • Bio-Rad Laboratories Inc.
  • Bio-Techne
  • Cytiva
  • Fujifilm Irvine Scientific
  • Miltenyi Biotec
  • Proteintech Group Inc.
  • Qiagen
  • Revvity
  • Sartorius Cellgenix GmbH
  • Stemcell Technologies
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages136
PublishedNovember 2024
Forecast Period2024 - 2029
Estimated Market Value ( USD ) in 2024 $ 10 Billion
Forecasted Market Value ( USD ) by 2029 $ 16.7 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Cell and Gene Therapies - Current and Future Landscape - Product Image

Cell and Gene Therapies - Current and Future Landscape

  • Report
  • 82 Pages
  • Global
From
Cell & Gene Therapies in CNS Disorders - Update - Product Image

Cell & Gene Therapies in CNS Disorders - Update

  • Report
  • 46 Pages
  • Global
From
Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Cell and Gene Therapy Clinical Trial Services - Global Strategic Business Report - Product Image

Cell and Gene Therapy Clinical Trial Services - Global Strategic Business Report

  • Report
  • 154 Pages
  • Global
From
Cell & Gene Therapy Manufacturing Services Market Report 2025 - Product Image

Cell & Gene Therapy Manufacturing Services Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.